Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials

References

• Ferrer M, Torres A. Epidemiology of ICU-acquired pneumonia. Curr Opin Crit Care. 2018;24(5):325–331.
   PubMed Web of Science ®Google Scholar
• Schreiber MP, Shorr AF. Challenges and opportunities in the treatment of ventilator-associated pneumonia. Expert Rev Anti Infect Ther. 2017;15(1):23–32.
   PubMed Web of Science ®Google Scholar
• Muscedere J, Sinuff T, Heyland DK, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013;144(5):1453–1460.
   PubMedGoogle Scholar
• Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312–1317.
   PubMed Web of Science ®Google Scholar
• Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13(8):665–671.
   PubMed Web of Science ®Google Scholar
• Relman DA. The human microbiome and the future practice of medicine. Jama. 2015;314(11):1127–1128.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Bandera A, Gori A. Therapeutic potential of the gut microbiota in the management of sepsis. Crit Care. 2020;24(1):105.
   PubMedGoogle Scholar
• Chen -C-C, Lai -C-C, Huang H-L, et al. Antimicrobial activity of lactobacillus species against carbapenem-resistant enterobacteriaceae. Front Microbiol. 2019;10:789.
   PubMed Web of Science ®Google Scholar
• Chen CC, Lai CC, Huang HL, et al. Antimicrobial ability and mechanism analysis of lactobacillus species against carbapenemase-producing enterobacteriaceae. J Microbiol Immunol Infect. 2021;54(3):447–456.
   PubMedGoogle Scholar
• Siempos II, Tk N, ME F. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38(3):954–962.
   PubMed Web of Science ®Google Scholar
• Bo L, Li J, Tao T, et al. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;10(10):Cd009066.
   Google Scholar
• van Ruissen Mce, Bos LD, Dickson RP, et al. Manipulation of the microbiome in critical illness-probiotics as a preventive measure against ventilator-associated pneumonia. Intensive Care Med Exp. 2019;7(Suppl 1):37.
   PubMedGoogle Scholar
• Su M, Jia Y, Li Y, et al. Probiotics for the prevention of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Respir Care. 2020;65(5):673–685.
   PubMedGoogle Scholar
• Zhao J, Li LQ, Chen CY, et al. Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis. ERJ Open Res. 2021;7(1):00302–2020.
   PubMedGoogle Scholar
• Ji T, Zhu X, Shang F, et al. preventive effect of probiotics on ventilator-associated pneumonia: a meta-analysis of 2428 patients. Ann Pharmacother. 2021;55(8):949–962.
   PubMedGoogle Scholar
• Batra P, Soni KD, Mathur P. Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. J Intensive Care. 2020;8:81.
   PubMedGoogle Scholar
• Gu WJ, Wei CY, Yin RX. Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Chest. 2012;142(4):859–868.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu KX, Ariani F, et al. Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials. PLoS One. 2013;8(12):e83934.
   PubMed Web of Science ®Google Scholar
• Johnstone J, Meade M, Lauzier F, et al. Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: a randomized clinical trial. Jama. 2021;326(11):1024–1033.
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103–112.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898.
   PubMed Web of Science ®Google Scholar
• AnAndArAj AM, Pichamuthu KK, Hansdak SG, et al. A randomised controlled trial of lactobacillus in the prevention of ventilator associated pneumonia. Journal of Clinical & Diagnostic Research. 2019;13(8):1-4.
   Google Scholar
• Barraud D, Blard C, Hein F, et al. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med. 2010;36(9):1540–1547.
   PubMed Web of Science ®Google Scholar
• Forestier C, Guelon D, Cluytens V, et al. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care. 2008;12(3):R69.
   PubMed Web of Science ®Google Scholar
• Knight DJ, Gardiner D, Banks A, et al. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med. 2009;35(5):854–861.
   PubMed Web of Science ®Google Scholar
• Kooshki A, Khazaei Z, Zarghi A, et al. Prebiotic prophylaxis of ventilator-associated pneumonia: a randomized clinical trial Biomed Res Ther. 2018;5(5):2287–2295
   Google Scholar
• Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006;30(10):1848–1855.
   PubMed Web of Science ®Google Scholar
• Mahmoodpoor A, Hamishehkar H, Asghari R, et al. Effect of a probiotic preparation on ventilator-associated pneumonia in critically Ill patients admitted to the intensive care unit: a prospective double-blind randomized controlled trial. Nutr Clin Pract. 2019;34(1):156–162.
   PubMedGoogle Scholar
• Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182(8):1058–1064.
   PubMed Web of Science ®Google Scholar
• Nazari B, Amani L, Ghaderi L, et al. Effects of probiotics on prevalence of ventilator-associated pneumonia in multitrauma patients hospitalized in neurosurgical intensive care unit: a randomized clinical trial Trauma Mon. 2020;25(6):262–268.
   Google Scholar
• Rongrungruang Y, Krajangwittaya D, Pholtawornkulchai K, et al. Randomized controlled study of probiotics containing lactobacillus casei (Shirota strain) for prevention of ventilator-associated pneumonia. J Med Assoc Thai. 2015;98(3):253–259.
   PubMedGoogle Scholar
• Shimizu K, Yamada T, Ogura H, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Crit Care. 2018;22(1):239.
   PubMedGoogle Scholar
• Tan M, Zhu JC, Du J, et al. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care. 2011;15(6):R290.
   PubMed Web of Science ®Google Scholar
• Zeng J, Wang CT, Zhang FS, et al. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med. 2016;42(6):1018–1028.
   PubMedGoogle Scholar
• Tsilika M, Thoma G, Aidoni Z, et al. A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial. Int J Antimicrob Agents. 2022;59(1):106471.
   PubMedGoogle Scholar